Maez Waibel lost more than 30 pounds in nine months on the new weight-loss drugs, sparking a substantial improvement in ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

Jon Gosselin detailed the ebbs and flows of his weight-loss journey, which included semaglutide and weight gain, but he's back on track, thanks to a new treatment.

The number of Australians taking weight-loss drugs is growing as new medicines hit the market. MPs warn the influx must be ...

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's pricing ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.